FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129764581> ?p ?o ?g. }

• W3129764581 endingPage "1464" @default.
• W3129764581 startingPage "1447" @default.
• W3129764581 abstract "Current guidelines recommend anticoagulation as the mainstay of portal vein thrombosis (PVT) treatment in cirrhosis. However, because of the heterogeneity of PVT, anticoagulation alone does not always achieve satisfactory results. This study aimed to prospectively evaluate an individualized management algorithm using a wait-and-see strategy (i.e., no treatment), anticoagulation, and transjugular intrahepatic portosystemic shunt (TIPS) to treat PVT in cirrhosis.Between February 2014 and June 2018, 396 consecutive patients with cirrhosis with nonmalignant PVT were prospectively included in a tertiary care center, of which 48 patients (12.1%) were untreated, 63 patients (15.9%) underwent anticoagulation, 88 patients (22.2%) underwent TIPS, and 197 patients (49.8%) received TIPS plus post-TIPS anticoagulation. The decision of treatment option mainly depends on the stage of liver disease (symptomatic portal hypertension or not) and degree and extension of thrombus.During a median 31.7 months of follow-up period, 312 patients (81.3%) achieved partial (n = 25) or complete (n = 287) recanalization, with 9 (3.1%) having rethrombosis, 64 patients (16.2%) developed major bleeding (anticoagulation-related bleeding in 7 [1.8%]), 88 patients (22.2%) developed overt hepatic encephalopathy, and 100 patients (25.3%) died. In multivariate competing risk regression models, TIPS and anticoagulation were associated with a higher probability of recanalization. Long-term anticoagulation using enoxaparin or rivaroxaban rather than warfarin was associated with a decreased risk of rethrombosis and an improved survival, without increasing the risk of bleeding. However, the presence of complete superior mesenteric vein thrombosis was associated with a lower recanalization rate, increased risk of major bleeding, and poor prognosis.In patients with cirrhosis with PVT, the individualized treatment algorithm achieves a high-probability recanalization, with low rates of portal hypertensive complications and adverse events." @default.
• W3129764581 created "2021-03-01" @default.
• W3129764581 creator A5002366018 @default.
• W3129764581 creator A5009582858 @default.
• W3129764581 creator A5019424035 @default.
• W3129764581 creator A5023597320 @default.
• W3129764581 creator A5031254409 @default.
• W3129764581 creator A5033870092 @default.
• W3129764581 creator A5051363890 @default.
• W3129764581 creator A5054318527 @default.
• W3129764581 creator A5060020912 @default.
• W3129764581 creator A5061017141 @default.
• W3129764581 creator A5061286118 @default.
• W3129764581 creator A5064489084 @default.
• W3129764581 creator A5074371798 @default.
• W3129764581 creator A5076425371 @default.
• W3129764581 creator A5078095351 @default.
• W3129764581 creator A5090617575 @default.
• W3129764581 creator A5091467952 @default.
• W3129764581 date "2021-02-25" @default.
• W3129764581 modified "2023-10-14" @default.
• W3129764581 title "Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study" @default.
• W3129764581 cites W1934397638 @default.
• W3129764581 cites W1976363057 @default.
• W3129764581 cites W1986644481 @default.
• W3129764581 cites W1987880263 @default.
• W3129764581 cites W1993340951 @default.
• W3129764581 cites W1997143480 @default.
• W3129764581 cites W2006440287 @default.
• W3129764581 cites W2011826456 @default.
• W3129764581 cites W2032537572 @default.
• W3129764581 cites W2040826870 @default.
• W3129764581 cites W2057659625 @default.
• W3129764581 cites W2070135776 @default.
• W3129764581 cites W2074180300 @default.
• W3129764581 cites W2139398552 @default.
• W3129764581 cites W2140237998 @default.
• W3129764581 cites W2143667169 @default.
• W3129764581 cites W2160633420 @default.
• W3129764581 cites W2172060670 @default.
• W3129764581 cites W2189690868 @default.
• W3129764581 cites W2194041294 @default.
• W3129764581 cites W2211816300 @default.
• W3129764581 cites W2310987636 @default.
• W3129764581 cites W2414255847 @default.
• W3129764581 cites W2533474819 @default.
• W3129764581 cites W2583115659 @default.
• W3129764581 cites W2592541035 @default.
• W3129764581 cites W2610258648 @default.
• W3129764581 cites W2725693452 @default.
• W3129764581 cites W2758879202 @default.
• W3129764581 cites W2766125910 @default.
• W3129764581 cites W2805775810 @default.
• W3129764581 cites W2806358017 @default.
• W3129764581 cites W2809833128 @default.
• W3129764581 cites W2886985238 @default.
• W3129764581 cites W2887652528 @default.
• W3129764581 cites W2901884599 @default.
• W3129764581 cites W2903882391 @default.
• W3129764581 cites W2921347694 @default.
• W3129764581 cites W2950337259 @default.
• W3129764581 cites W2962220644 @default.
• W3129764581 cites W2989714602 @default.
• W3129764581 cites W2998487497 @default.
• W3129764581 cites W571628560 @default.
• W3129764581 cites W606646802 @default.
• W3129764581 doi "https://doi.org/10.14309/ajg.0000000000001194" @default.
• W3129764581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33630766" @default.
• W3129764581 hasPublicationYear "2021" @default.
• W3129764581 type Work @default.
• W3129764581 sameAs 3129764581 @default.
• W3129764581 citedByCount "25" @default.
• W3129764581 countsByYear W31297645812021 @default.
• W3129764581 countsByYear W31297645812022 @default.
• W3129764581 countsByYear W31297645812023 @default.
• W3129764581 crossrefType "journal-article" @default.
• W3129764581 hasAuthorship W3129764581A5002366018 @default.
• W3129764581 hasAuthorship W3129764581A5009582858 @default.
• W3129764581 hasAuthorship W3129764581A5019424035 @default.
• W3129764581 hasAuthorship W3129764581A5023597320 @default.
• W3129764581 hasAuthorship W3129764581A5031254409 @default.
• W3129764581 hasAuthorship W3129764581A5033870092 @default.
• W3129764581 hasAuthorship W3129764581A5051363890 @default.
• W3129764581 hasAuthorship W3129764581A5054318527 @default.
• W3129764581 hasAuthorship W3129764581A5060020912 @default.
• W3129764581 hasAuthorship W3129764581A5061017141 @default.
• W3129764581 hasAuthorship W3129764581A5061286118 @default.
• W3129764581 hasAuthorship W3129764581A5064489084 @default.
• W3129764581 hasAuthorship W3129764581A5074371798 @default.
• W3129764581 hasAuthorship W3129764581A5076425371 @default.
• W3129764581 hasAuthorship W3129764581A5078095351 @default.
• W3129764581 hasAuthorship W3129764581A5090617575 @default.
• W3129764581 hasAuthorship W3129764581A5091467952 @default.
• W3129764581 hasConcept C126322002 @default.
• W3129764581 hasConcept C141071460 @default.
• W3129764581 hasConcept C2776301958 @default.
• W3129764581 hasConcept C2777075537 @default.
• W3129764581 hasConcept C2777214474 @default.

• next